OSSU.Y Stock Overview
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Embla Medical hf. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.9.00 |
| 52 Week High | kr.11.00 |
| 52 Week Low | kr.4.05 |
| Beta | 0.62 |
| 1 Month Change | 100.00% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 93.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| OSSU.Y | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 100.0% | -0.4% | 1.0% |
| 1Y | n/a | 0.008% | 27.2% |
Return vs Industry: Insufficient data to determine how OSSU.Y performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how OSSU.Y performed against the US Market.
Price Volatility
| OSSU.Y volatility | |
|---|---|
| OSSU.Y Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: OSSU.Y's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine OSSU.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 4,000 | Sveinn Solvason | www.ossur.com |
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated.
Embla Medical hf. Fundamentals Summary
| OSSU.Y fundamental statistics | |
|---|---|
| Market cap | US$1.78b |
| Earnings (TTM) | US$56.93m |
| Revenue (TTM) | US$804.32m |
31.3x
P/E Ratio2.2x
P/S RatioIs OSSU.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSSU.Y income statement (TTM) | |
|---|---|
| Revenue | US$804.32m |
| Cost of Revenue | US$310.36m |
| Gross Profit | US$493.96m |
| Other Expenses | US$437.03m |
| Earnings | US$56.93m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 23, 2024
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 61.41% |
| Net Profit Margin | 7.08% |
| Debt/Equity Ratio | 57.4% |
How did OSSU.Y perform over the long term?
See historical performance and comparison